Author

Y. Yeh

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Organism:human· 3 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:database / resource· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Assay:protein sequence· 1

Frequent Co-Authors

S. Cheng· 3 shared X. Yu· 3 shared E. Corey· 2 shared L. Li· 2 shared Y. Shi· 2 shared A. Lurie· 1 shared A. Watkins· 1 shared B. Rushing· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 32 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

S. Cheng

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The expression of PKM1 and PKM2 in developing, benign, and cancerous prostatic tissues

L. Li, S. Cheng, Y. Yeh, Y. Shi, N. Henderson, D. Price, X. Gu, X. Yu

This study examines PKM1 and PKM2 expression in mouse and human prostatic tissues across development, benign, and cancerous states, revealing distinct patterns in PCa and NEPCa.

bioRxiv · Sep 27, 2023Cancer Biology

Unveiling Novel Double-Negative Prostate Cancer Subtypes Through Single-Cell RNA Sequencing Analysis

S. CHENG, L. Li, Y. Yeh, Y. Shi, O. Franco, E. Corey, X. Yu

This study identifies two novel double-negative prostate cancer subtypes using scRNA-seq and develops a web tool for visualization.

bioRxiv · Aug 11, 2023 · PreprintCancer Biology

The expression of YAP1 is increased in high-grade prostatic adenocarcinoma but is reduced in neuroendocrine prostate cancer

S. Cheng, N. Prieto-Dominguez, S. Yang, Z. Connelly, S. StPierre, B. Rushing, A. Watkins, L. Shi, M. Lakey, L. Baiamonte, T. Fazili, A. Lurie, E. Corey, R. Shi, Y. Yeh, X. Yu

This study shows YAP1 is increased in high-grade prostate adenocarcinoma but reduced in neuroendocrine prostate cancer, with YAP1 loss activating Wnt/beta-Catenin signaling linked to NEPC development.

bioRxiv · Nov 6, 2019Cancer Biology